Mount Sinai Medical Center: Mesothelioma Treatment
The Mount Sinai Medical Center, located in New York City’s Upper East Side, consists of both the Mount Sinai Hospital and the Mount Sinai School of Medicine. In 2008, the 1,171 bed center treated almost 60,000 inpatients and nearly 530,000 outpatients.
For 2009-2010, it ranked 19th in the America’s Best Hospitals issue of U.S. News & World Reports, with its cancer treatment program singled out as one of the best in the country as well.
Founded in 1968, the School of Medicine ranked 18th on U.S. News & World Reports’ ranking of medical schools for 2009-2010. As of August 2009 it contained 516 medical students and received $311 million in grant funding.
Mesothelioma cancer patients who are receiving treatment at Mount Sinai will likely do so at their Thoracic Oncology program, a sub-specialty program of the Division of Pulmonary, Critical Care, and Sleep Medicine in the hospital’s Department of Medicine. The program offers a number of evaluation services, such as CT and PET scans, fiberoptic and rigid brochoscopy, and video-assisted thoracoscopies.
Following a diagnosis, the hospital can provide various treatments to either fight the mesothelioma cancer or perform palliative techniques to prolong a patient’s life in as comfortable a manner as is possible.
Mount Sinai has also made progress in its use of more experimental types of treatment, such the use of small catheters to administer treatments to patients suffering from malignant pleural effusions. In many cases, the treatment requires no stay in the hospital.
Patients who are undergoing
mesothelioma treatment may be able to pursue legal options to receive a
mesothelioma settlement if their illness has been caused by
asbestos exposure.
Mesothelioma attorneys are a reliable source to seek out if a patient, or the family members of one who is suffering from the disease, has questions about
asbestos laws.